ELITE PHARMACEUTICALS INC /DE/ (ELI) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 45 transactions totaling $353.7K, demonstrating a bullish sentiment with $28.9K in net insider flow. The most recent transaction on Jul 21, 2009 involved a sale of 138,528 shares valued at $8.3K.
No significant insider buying has been recorded for ELI in the recent period.
No significant insider selling has been recorded for ELI in the recent period.
Based on recent SEC filings, insider sentiment for ELI is bullish with an Insider Alignment Score of 54/100 and a net flow of $28.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ELITE PHARMACEUTICALS INC /DE/ (ELI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading ELI stock, having executed 45 transactions in the past 90 days. The most active insider is Charan Behl (Executive), who has made 27 transactions totaling $116.8K.
Get notified when executives and directors at ELI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 21, 2009 | Company, Llc Trellus Management | Executive | Sale | 138,528 | $0.06 | $8.3K | |
| Jul 15, 2009 | Company, Llc Trellus Management | Executive | Sale | 561,342 | $0.07 | $39.3K | |
| May 28, 2009 | Company, Llc Trellus Management | Executive | Other | 308,419 | $N/A | $0 | |
| Apr 8, 2009 | Lp Trellus Partners | Executive | Sale | 393,200 | $0.13 | $51.1K | |
| Apr 6, 2009 | Lp Trellus Partners | Executive | Sale | 174,252 | $0.15 | $26.1K | |
| Apr 3, 2009 | Lp Trellus Partners | Executive | Sale | 220,700 | $0.17 | $37.5K | |
| Sep 19, 2008 | Behl Charan | Executive | Purchase | 10,000 | $0.09 | $900 | |
| Jul 23, 2008 | Behl Charan | Executive | Purchase | 10,000 | $0.34 | $3.4K | |
| Jul 23, 2008 | Behl Charan | Executive | Purchase | 9,300 | $0.34 | $3.2K | |
| Jul 23, 2008 | Behl Charan | Executive | Purchase | 700 | $0.32 | $224 | |
| Jul 21, 2008 | Behl Charan | Executive | Purchase | 744 | $0.35 | $260 | |
| Jul 21, 2008 | Behl Charan | Executive | Purchase | 9,256 | $0.38 | $3.5K | |
| Jul 18, 2008 | Behl Charan | Executive | Purchase | 10,000 | $0.37 | $3.7K | |
| Jul 17, 2008 | Behl Charan | Executive | Purchase | 15,000 | $0.35 | $5.3K | |
| Jul 15, 2008 | Behl Charan | Executive | Purchase | 5,000 | $0.34 | $1.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 38 | $191.3K | 51.8% |
Sale(S) | 5 | $162.4K | 44.0% |
Payment(F) | 1 | $15.7K | 4.2% |
Other(J) | 1 | $0 | 0.0% |
Insider activity at ELITE PHARMACEUTICALS INC /DE/ shows mixed signals across all time. While $191.3K in purchases indicates some executive confidence,$162.4K in sales balances the picture, resulting in a modest net flow of $28.9K.6 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Charan Behl, has transacted $116.8K during this period.